Vassyl Lonchyna to Follow-Up Studies
This is a "connection" page, showing publications Vassyl Lonchyna has written about Follow-Up Studies.
Connection Strength
0.005
-
Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol. 1995 Aug; 13(8):1880-92.
Score: 0.005